An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study.
Kristina Secnik BoyeJay P BaeVivian T ThieuMaureen J LagePublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Glycemic control was associated with significantly lower all-cause total, drug, and acute care medical costs. Given the high prevalence of T2D in the USA, our results suggest potential economic benefits associated with glycemic control for healthcare providers.